RSV in the NewsThe cold months are upon us! As the temperature drops, so do our chances of staying healthy. Unfortunately, this means that respiratory infections like RSV (respiratory syncytial virus) are on... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments0 comments
Cigarette Maker Transitioning to Inhalers?Phillip Morris has been in the news recently. The word is that they have purchased Vectura, a company that makes inhalers and nebulizers. So this begins the transition of a... By John Bottrell, RRT3 min readBookmark for laterReactions 0 reactions Comments0 comments
Philips Ventilator Recall: What You Need to KnowPhilips Respironics has recalled more than 16,000 ventilators in the United States due to a problem with the machines' oxygen flow. The recall affects 2 ventilator models sold between May... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments0 comments
What to Know About Philips CPAP and Ventilator RecallAfter many months of investigation, Philips has announced a recall notification for many of its devices. The medical device company analyzed risks related to several products, including:1,2 In the United... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments1 comments
Breztri Aerosphere™ Approved to Treat COPDBreztri Aerosphere is a single-inhaler, fixed-dose combination of 3 drugs that has been approved by the FDA for the maintenance treatment of COPD. It was formerly known as PT010.1 The... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments0 comments
FDA Approves First Generic of Proventil HFA, A Commonly Used Albuterol InhalerThe United States Food and Drug Administration (US FDA) has approved the first generic of Proventil HFA metered-dose inhaler. This is an especially important approval for the COVID-19 pandemic response... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments0 comments
Take the Fatigue and Health Survey!The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic... By Editorial Team1 min readBookmark for laterReactions 0 reactions Comments0 comments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments4 comments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can... By Editorial Team5 min readBookmark for laterReactions 0 reactions Comments5 comments
Congratulations to New York State!The State of New York just raised the minimum age required to purchase tobacco and electronic cigarette products age from 18 to 21. The law went into effect November 13... By KevinDavitt3 min readBookmark for laterReactions 0 reactions Comments3 comments
Grace Anne Dorney Koppel & Ted Koppel Raise Awareness for COPD on CBS Morning NewsMany of you may know Ted Koppel as the former anchor of Nightline but you may not know his wife Grace Anne Dorney Koppel. Grace Anne was diagnosed with COPD... By Ann D. Cuccia, MPH RRT2 min readBookmark for laterReactions 0 reactions Comments2 comments
Bevespi® Inhaler Approved by FDAMany of you may have seen the recent press release about the new drug Bevespi® that has been approved for COPD by the FDA. This new medication combines 2 classes... By Ann D. Cuccia, MPH RRT3 min readBookmark for laterReactions 0 reactions Comments1 comments
Change Your Avatar for COPD Awareness MonthNovember is COPD Awareness Month! One way to spread awareness is to change your avatar (profile image) across social media sites. You can download any of the images to use as your... By Editorial Team1 min readBookmark for laterReactions 0 reactions Comments0 comments
